BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2785116)

  • 1. HeLa cell mutants resistant to epidermal growth factor ricin A-chain conjugate.
    Banker D; Herschman HR
    J Cell Physiol; 1989 Apr; 139(1):42-50. PubMed ID: 2785116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
    Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
    J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
    Banker DE; Pastan I; Gottesman MM; Herschman HR
    J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic ligand conjugates as tools in the study of receptor-ligand interactions.
    Herschman HR; Simpson DL; Cawley DB
    J Cell Biochem; 1982; 20(2):163-76. PubMed ID: 6188758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
    Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
    Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered degradation of epidermal growth factor in a diphtheria toxin-resistant clone of KB cells.
    Haigler HT; Wiley HS; Moehring JM; Moehring TJ
    J Cell Physiol; 1985 Aug; 124(2):322-30. PubMed ID: 3876344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic.
    Cawley DB; Herschman HR; Gilliland DG; Collier RJ
    Cell; 1980 Nov; 22(2 Pt 2):563-70. PubMed ID: 6256086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of epidermal growth factor receptor in a rat thyroid cell line, FRTL-5.
    Sugawa H; Beniko M; Imura H; Mori T
    Biochem Biophys Res Commun; 1993 May; 193(1):390-7. PubMed ID: 8389148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and properties of chimeric toxins prepared from the constituent polypeptides of diphtheria toxin and ricin. Evidence for entry of ricin A-chain via the diphtheria toxin pathway.
    Sundan A; Olsnes S; Sandvig K; Pihl A
    J Biol Chem; 1982 Aug; 257(16):9733-9. PubMed ID: 7107588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
    Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin.
    Simpson DL; Cawley DB; Herschman HR
    Cell; 1982 Jun; 29(2):469-73. PubMed ID: 6180832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the epidermal growth factor receptor in breast cancer cell lines with a recombinant ligand fusion toxin (DAB389EGF).
    Osborne CK; Coronado-Heinsohn E
    Cancer J Sci Am; 1996; 2(3):175-80. PubMed ID: 9166518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
    Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
    J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells.
    Liu TF; Cohen KA; Ramage JG; Willingham MC; Thorburn AM; Frankel AE
    Cancer Res; 2003 Apr; 63(8):1834-7. PubMed ID: 12702570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic and cytotoxic activities of recombinant ricin A chain mutants with charged residues added at the carboxyl terminus.
    Simpson JC; Roberts LM; Lord JM
    Protein Expr Purif; 1995 Oct; 6(5):665-70. PubMed ID: 8535160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.
    Burgaud JL; Baserga R
    Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of epidermal growth factor receptor and transforming growth factor production in drug resistant variants derived from adenovirus transformed cells.
    Sircar S; Weber JM
    J Cell Physiol; 1988 Mar; 134(3):467-72. PubMed ID: 3258314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.